CLPT
ClearPoint Neuro, Inc.
NasdaqCMUSDEQUITY
DELAYED
Last price
15.25
▲ 0.06 (0.40%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
15.43
Prev close
15.19
Day high
15.53
Day low
14.97
Volume
551.71K
Market cap
—
P/E (TTM)
—
52W range
8.27 – 30.10
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+0.33%
+1.7%
1M
+6.21%
+2.5%
3M
+31.54%
+28.4%
6M
+8.76%
-2.3%
YTD
+12.50%
+0.2%
1Y
+48.41%
+28.4%
3Y
+171.43%
+97.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $36.97M | $31.39M | $23.95M | $20.55M | +17.8% |
| Operating revenue | $36.97M | $31.39M | $23.95M | $20.55M | +17.8% |
| Cost of revenue | $14.28M | $12.27M | $10.34M | $7.02M | +16.4% |
| Gross profit | $22.69M | $19.12M | $13.61M | $13.53M | +18.7% |
| Research & development | $13.90M | $12.39M | $11.71M | $10.89M | +12.1% |
| Selling, general & admin | $32.96M | $26.46M | $24.35M | $18.97M | +24.5% |
| Total operating expense | $46.86M | $38.86M | $36.06M | $29.86M | +20.6% |
| Operating income | -$24.16M | -$19.73M | -$22.45M | -$16.33M | -22.4% |
| Net interest income | -$1.18M | $872.00K | $386.00K | -$81.00K | -234.7% |
| Pre-tax income | -$25.48M | -$18.90M | -$22.09M | -$16.43M | -34.8% |
| Tax provision | $55.00K | $12.00K | — | — | +358.3% |
| Net income | -$25.54M | -$18.91M | -$22.09M | -$16.43M | -35.0% |
| Net income to common | -$25.54M | -$18.91M | -$22.09M | -$16.43M | -35.0% |
| Basic EPS | -0.90 | -0.70 | -0.90 | -0.68 | -28.6% |
| Diluted EPS | -0.90 | -0.70 | -0.90 | -0.68 | -28.6% |
| EBIT | -$23.10M | -$18.38M | -$22.45M | -$16.35M | -25.6% |
| EBITDA | -$20.86M | -$16.48M | -$20.99M | -$15.58M | -26.6% |
| Basic shares | 28.32M | 27.03M | 24.61M | 24.18M | +4.8% |
| Diluted shares | 28.32M | 27.03M | 24.61M | 24.18M | +4.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $45.92M | $20.10M | $23.14M | $27.61M | — | +128.4% |
| Cash & short-term investments | $45.92M | $20.10M | $23.14M | $37.49M | — | +128.4% |
| Accounts receivable | $6.55M | $4.71M | $3.21M | $2.67M | — | +39.0% |
| Inventory | $8.36M | $6.86M | $7.91M | $9.30M | — | +21.8% |
| Total current assets | $63.60M | $33.36M | $36.17M | $51.18M | — | +90.6% |
| Property, plant & equipment | $11.05M | $5.09M | $4.95M | $2.70M | — | +117.1% |
| Goodwill & intangibles | $21.39M | $0 | $1.04M | $1.03M | — | — |
| Total assets | $97.75M | $39.19M | $42.66M | $55.49M | — | +149.4% |
| Total current liabilities | $10.77M | $10.35M | $7.43M | $6.79M | — | +4.0% |
| Long-term debt | $49.08M | — | $9.95M | $9.89M | $9.84M | — |
| Total debt | $58.23M | $3.57M | $13.94M | $11.99M | — | +1,532.1% |
| Total liabilities | $69.73M | $13.80M | $21.49M | $18.60M | — | +405.3% |
| Retained earnings | -$216.91M | -$191.37M | -$172.46M | -$150.37M | — | -13.3% |
| Shareholder equity | $28.02M | $25.39M | $21.17M | $36.89M | — | +10.4% |
| Working capital | $52.84M | $23.01M | $28.74M | $44.39M | — | +129.6% |
| Net tangible assets | $6.63M | $25.39M | $20.13M | $35.86M | — | -73.9% |
| Shares issued | 29.37M | 27.62M | 24.65M | 24.58M | — | +6.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$25.54M | -$18.91M | -$22.09M | -$16.43M | -35.0% |
| Depreciation & amortisation | $2.24M | $1.90M | $1.46M | $777.00K | +17.6% |
| Stock-based compensation | $8.18M | $6.91M | $6.08M | $4.13M | +18.4% |
| Change in working capital | -$9.81M | $1.40M | -$356.00K | -$4.29M | -801.5% |
| Operating cash flow | -$23.93M | -$8.95M | -$13.72M | -$16.17M | -167.3% |
| Capital expenditure | -$522.00K | -$275.00K | -$1.05M | -$1.15M | -89.8% |
| Investing cash flow | $615.00K | -$275.00K | $8.95M | -$10.74M | +323.6% |
| Financing cash flow | $50.18M | $6.19M | $296.00K | $409.00K | +710.8% |
| Free cash flow | -$24.45M | -$9.22M | -$14.77M | -$17.31M | -165.0% |
| End cash position | $46.97M | $20.10M | $23.14M | $27.61M | +133.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $10.88M | $12.13M | $10.41M | $8.86M | $9.21M | — | -10.3% |
| Operating revenue | $10.88M | $12.13M | $10.41M | $8.86M | $9.21M | — | -10.3% |
| Cost of revenue | $4.17M | $4.37M | $4.01M | $3.26M | $3.66M | — | -4.6% |
| Gross profit | $6.71M | $7.76M | $6.40M | $5.60M | $5.56M | — | -13.5% |
| Research & development | $4.63M | $4.52M | $3.24M | $3.45M | $3.83M | — | +2.4% |
| Selling, general & admin | $12.32M | $11.71M | $10.21M | $7.42M | $7.41M | — | +5.2% |
| Total operating expense | $16.95M | $16.23M | $13.45M | $10.88M | $11.24M | — | +4.4% |
| Operating income | -$10.24M | -$8.48M | -$7.04M | -$5.28M | -$5.68M | — | -20.8% |
| Net interest income | -$1.12M | -$1.03M | -$703.00K | -$543.00K | -$80.00K | — | -9.0% |
| Pre-tax income | -$11.38M | -$9.54M | -$7.78M | -$5.88M | -$5.81M | — | -19.2% |
| Tax provision | -$38.00K | $8.00K | $4.00K | $8.00K | $25.00K | — | -575.0% |
| Net income | -$11.34M | -$9.55M | -$7.79M | -$5.89M | -$5.84M | — | -18.7% |
| Net income to common | -$11.34M | -$9.55M | -$7.79M | -$5.89M | -$5.84M | — | -18.7% |
| Basic EPS | -0.38 | -0.32 | — | -0.21 | -0.21 | -0.22 | -18.8% |
| Diluted EPS | -0.38 | -0.32 | — | -0.21 | -0.21 | -0.22 | -18.8% |
| EBIT | -$9.96M | -$8.16M | -$5.87M | -$5.34M | -$5.45M | — | -22.1% |
| EBITDA | -$8.59M | -$7.05M | -$5.01M | -$4.91M | -$4.82M | — | -21.8% |
| Basic shares | 30.17M | 29.55M | — | 28.43M | 28.26M | 27.72M | +2.1% |
| Diluted shares | 30.17M | 29.55M | — | 28.43M | 28.26M | 27.72M | +2.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $29.36M | $35.59M | $45.92M | $38.22M | $41.54M | — | -17.5% |
| Cash & short-term investments | $29.36M | $35.59M | $45.92M | $38.22M | $41.54M | — | -17.5% |
| Accounts receivable | $8.39M | $8.66M | $6.55M | $4.00M | $4.26M | — | -3.1% |
| Inventory | $8.81M | $8.57M | $8.36M | $6.58M | $6.29M | — | +2.8% |
| Total current assets | $48.93M | $54.88M | $63.60M | $51.33M | $53.99M | — | -10.8% |
| Property, plant & equipment | $15.63M | $16.00M | $11.05M | $8.07M | $8.16M | — | -2.3% |
| Goodwill & intangibles | $20.39M | $20.89M | $21.39M | — | — | $565.00K | -2.4% |
| Total assets | $86.74M | $93.42M | $97.75M | $60.36M | $62.87M | — | -7.1% |
| Total current liabilities | $10.31M | $9.48M | $10.77M | $8.05M | $7.40M | — | +8.8% |
| Long-term debt | $50.23M | $49.64M | $49.08M | $29.20M | $28.84M | — | +1.2% |
| Total debt | $63.95M | $63.59M | $58.23M | $35.74M | $35.46M | — | +0.6% |
| Total liabilities | $75.97M | $74.58M | $69.73M | $44.48M | $43.13M | — | +1.9% |
| Retained earnings | -$237.80M | -$226.46M | -$216.91M | -$209.12M | -$203.23M | — | -5.0% |
| Shareholder equity | $10.78M | $18.84M | $28.02M | $15.87M | $19.74M | — | -42.8% |
| Working capital | $38.62M | $45.40M | $52.84M | $43.28M | $46.59M | — | -14.9% |
| Net tangible assets | -$9.61M | -$2.05M | $6.63M | $15.87M | $19.74M | — | -368.8% |
| Shares issued | 30.50M | 29.99M | 29.37M | 28.43M | 28.27M | — | +1.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$11.34M | -$9.55M | -$7.79M | -$5.89M | -$5.84M | -18.7% |
| Depreciation & amortisation | $1.37M | $1.11M | $851.00K | $426.00K | $626.00K | +23.5% |
| Stock-based compensation | $2.27M | $2.22M | $1.98M | $2.02M | $2.27M | +2.4% |
| Change in working capital | $122.00K | -$2.22M | -$7.37M | -$35.00K | $197.00K | +105.5% |
| Operating cash flow | -$7.01M | -$7.97M | -$12.08M | -$3.12M | -$2.55M | +11.9% |
| Capital expenditure | -$214.00K | -$645.00K | -$49.00K | -$199.00K | -$91.00K | +66.8% |
| Investing cash flow | -$214.00K | -$645.00K | $1.09M | -$199.00K | -$91.00K | +66.8% |
| Financing cash flow | $1.00M | -$1.84M | $19.56M | $0 | $31.98M | +154.3% |
| Free cash flow | -$7.23M | -$8.61M | -$12.13M | -$3.32M | -$2.64M | +16.1% |
| End cash position | $30.29M | $36.52M | $46.97M | $38.40M | $41.72M | -17.1% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
15.26
-0.08% from price
SMA 20
14.72
+4.54% from price
SMA 50
15.77
-2.41% from price
SMA 100
13.56
+12.48% from price
SMA 200
13.48
+14.19% from price
EMA 12
15.15
+0.68% from price
EMA 26
15.10
+1.03% from price
EMA 50
14.91
+2.31% from price
RSI (14)
52.4
Neutral
MACD (12,26,9)
0.05
Hist 0.16
ATR (14)
0.82
5.31% of price
Realised vol 30D
69.0%
Annualised
Bollinger upper
16.33
20, 2σ
Bollinger lower
13.12
20, 2σ
50 / 200 cross
Golden
15.77 vs 13.48
Trend bias
Above 200
+14.19%
Risk profile
Beta vs SPY
1.76
More volatile than market
Correlation to SPY
0.21
Largely independent
Realised vol 30D
69.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-70.7%
Peak to trough
Max drawdown 5Y
-77.3%
Peak to trough
ATR 14
0.82
5.31% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript
Motley Fool · 12d ago
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary
Moby · 18d ago
ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks · 19d ago
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
Zacks · 19d ago
ClearPoint Neuro Q2 Earnings Call Highlights
MarketBeat · 19d ago
ClearPoint Neuro Reports Second Quarter 2026 Results
ACCESS Newswire · 19d ago
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel
ACCESS Newswire · 22d ago
Earnings To Watch: ClearPoint Neuro Inc (CLPT) Q2 2026 -- GF Value Sees 28% Upside
GuruFocus.com · 22d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.